Table 2.
Variable | Graft Survival | Patient Survival | ||
---|---|---|---|---|
Hazard Ratio | 95% Confidence Interval | Hazard Ratio | 95% Confidence Interval | |
Etiology vs chronic cholestatic liver disease | ||||
HCV | 1.61 | 1.52‐1.74 | 1.97 | 1.84‐2.11 |
Alcoholic liver disease | 1.28 | 1.2‐1.69 | 1.64 | 1.52‐1.77 |
Alcoholic liver disease + HCV | 1.6 | 1.46‐1.69 | 2.1 | 1.9‐2.23 |
Nonalcoholic steatohepatitis | 1.19 | 1.04‐1.37 | 1.52 | 1.3‐1.77 |
Chronic cholestatic | 1.27 | 1.18‐1.35 | 1.53 | 1.42‐1.66 |
Hepatitis B virus | 1.07 | 0.96‐1.19 | 1.3 | 1.15‐1.47 |
Hepatocellular carcinoma | 1.67 | 1.56‐1.78 | 2.15 | 1.99‐2.32 |
Age increase (for every 10 years) | 1.09 | 1.07‐1.11 | 1.24 | 1.22‐1.27 |
Female versus male | 0.99 | 0.96‐1.03 | 1.05 | 1.01‐1.09 |
African American versus Caucasian | 1.28 | 1.21‐1.36 | 1.33 | 1.24‐1.42 |
Ventilator support | 1.85 | 1.67‐2.05 | 1.63 | 1.44‐1.84 |
Model for End‐Stage Liver Disease score increase (for every 3 points) | 1.03 | 1.03‐10.4 | 1.05 | 1.04‐1.06 |
This table has been adapted with permission from Transplantation.23 Copyright 2013, Transplantation Society.